Gainers

• Pulsenmore (NASDAQ:PLSM) shares moved upwards by 160.5% to $8.88 during Wednesday's regular session. The market value of their outstanding shares is at $22.1 million.
• Icecure Medical (NASDAQ:ICCM) stock moved upwards by 46.4% to $8.96. The market value of their outstanding shares is at $515.3 million.
• Cuprina Holdings (Cayman) (NASDAQ:CUPR) shares increased by 40.35% to $5.53. The company's market cap stands at $10.5 million.
• Catheter Precision (AMEX:VTAK) stock rose 39.13% to $1.28. The market value of their outstanding shares is at $2.4 million.
• Absci (NASDAQ:ABSI) stock increased by 34.61% to $9.97. The market value of their outstanding shares is at $1.1 billion.
• Nuvectis Pharma (NASDAQ:NVCT) shares increased by 33.21% to $23.38. The market value of their outstanding shares is at $465.5 million.

Losers

• Aditxt (NASDAQ:ADTX) shares fell 72.7% to $0.01 during Wednesday's regular session.
• Atlantic International (NASDAQ:ATLN) shares declined by 41.23% to $0.78. The company's market cap stands at $101.3 million. As per the press release, Q1 earnings came out 2 days ago.
• Cognition Therapeutics (NASDAQ:CGTX) shares decreased by 32.13% to $1.12. The company's market cap stands at $147.6 million.
• CalciMedica (NASDAQ:CALC) stock declined by 23.74% to $0.61. The company's market cap stands at $12.6 million.
• Veraxa Biotech Holding (NASDAQ:VRXA) stock declined by 22.0% to $2.27. The market value of their outstanding shares is at $411.4 million.
• Mobile-health Network (NASDAQ:MNDR) shares fell 20.72% to $0.45. The company's market cap stands at $4.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.